GlaxoSmithKline PLC Director/PDMR Shareholding (4041Q)
18 Junio 2020 - 6:25AM
UK Regulatory
TIDMGSK
RNS Number : 4041Q
GlaxoSmithKline PLC
18 June 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
==== ==============================================================================================
a) Name Ms D Waterhouse
==== ======================================== ====================================================
b) Position/status CEO of ViiV Healthcare
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ====================================================
b) Nature of the Following the final vesting on 15 June
transaction 2020 of an award made on 15 June 2017 under
the GlaxoSmithKline Deferred Investment
Award programme, Ms Waterhouse will receive
a cash payment of GBP75,564.47 less applicable
tax withholding in respect of 4,720.419
notional Ordinary Shares.
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =========================
16.008 4,720.419
====================== =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ========================================================
e) Date of the transaction 2020-06-15
==== ======================================== ====================================================
f) Place of the N/A
transaction
==== ======================================== ====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFVLFFBQLLBBX
(END) Dow Jones Newswires
June 18, 2020 07:25 ET (11:25 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De May 2023 a May 2024